Previous 10 | Next 10 |
CAMBRIDGE, Mass., May 28, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that its 2020 Annual Meeting of Stockholders has been c...
Are These On Your List Of Penny Stocks To Watch Before June 2020? The stock market today is jumping again and so are a number of penny stocks . One thing brought to my attention was the misconception that penny stocks are meant for short-term day trades. Now, before I get to my point, let me ...
Surface Oncology (NASDAQ: SURF ) is off 2.1% after hours following its entry into an at-the-market sales agreement with JonesTrading. More news on: Surface Oncology, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Gainers: Surface Oncology (NASDAQ: SURF ) +82% . More news on: Surface Oncology, Inc., Nabors Industries Ltd., LMP Automotive Holdings, Inc., Stocks on the move, , Read more ...
Gainers: Renren (NYSE: RENN ) +66% . More news on: Renren Inc., SemiLEDs Corporation, Cheetah Mobile Inc., Stocks on the move, , Read more ...
Safe-T Group (NASDAQ: SFET ) +44% as its wholly owned subsidiary, NetNut has expanded into a new market with the signing of agreements with three leading companies operating in the consumer VPN sector. More news on: Safe-T Group Ltd, Surface Oncology, Inc., Cheetah Mobile Inc., St...
Surface Oncology (NASDAQ: SURF ) is up 35% premarket after entering into a clinical trial collaboration with Merck (NYSE: MRK ) to evaluate the safety and efficacy of combining Surface’s SRF617, an investigational antibody therapy targeting CD39, with Merck...
CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today that it has raised gross proceeds of approximately $28.9 mi...
CAMBRIDGE, Mass., May 20, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, announced today it has entered into a clinical trial collaboration with Me...
CAMBRIDGE, Mass., May 15, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced five scientific posters sharing updated preclinical data a...
News, Short Squeeze, Breakout and More Instantly...
Surface Oncology Inc. Company Name:
SURF Stock Symbol:
NASDAQ Market:
Surface Oncology Inc. Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Surface Oncology Inc. (SURF) is expected to report $-0.36 for Q3 2023
CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (NASDAQ:SURF) ("Surface"), a clinical-stage immuno-oncology company d...